Galera Therapeutics Inc (GRTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché GRTX Giù? Forum Previsione

Galera Therapeutics Inc Azioni (GRTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi
Research and Development	19.42% 6.093	7.561	7.272
Interest Income/Expense	147.44% -2.087	4.399	4.223
Operating Income/Loss	20.30% -13.40	-16.81	-13.88
Income/Loss From Continuing Operations Before Tax	27.23% -15.07	-20.71	-17.71
Income/Loss From Continuing Operations After Tax	27.23% -15.07	-20.71	-17.71
Net Income/Loss	27.23% -15.07	-20.71	-17.71
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Basic Average Shares	5.97% 45.48	42.92	35.20
Diluted Average Shares	5.97% 45.48	42.92	35.20
Basic Earnings Per Share	31.25% -0.33	-0.48	-0.50
Diluted Earnings Per Share	168.75% -0.33	0.48	-0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

GMAB

$20.52

1.08%

RPRX

$35.59

2.14%

SMMT

$22.61

7.90%

INSM

$96.95

0.87%

BNTX

$110.05

0.05%

ONC

$240.99

1.83%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto su Reuters